On November 1, 2023, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock, payable on December 4, 2023 to shareholders of record on November 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.13 USD | -1.57% | +1.28% | +2.66% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.66% | 850M | |
+16.68% | 17.52B | |
-16.69% | 2.74B | |
-12.60% | 2.67B | |
-27.97% | 1.82B | |
-5.00% | 1.13B | |
-9.36% | 1.04B | |
-15.24% | 790M | |
-1.66% | 748M | |
-25.57% | 663M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories Inc. Approves Cash Dividend for the Fourth Quarter of 2023, Payable on December 4, 2023